Glenmark received US FDA approval for it's Baddi Plant

Thebullishtrends: Glenmark Pharma shares are trading at Rs.500(0.22%) Glenmark Pharmaceuticals Ltd one of India's leading research led integrated pharmaceutical companies, has received US FDA approval for its state of the art semi-solids(Ointments and Creams) manufacturing plant at Baddi Himachal Pradesh. This is the third Glenmark manufacturing plant to have been approved by US FDA. The Baddi plant recently received GMP approval from MHRA of UK and from TPD Canada. The US FDA approval will enable Glenmark to enter the niche segment of semi-solid dosages in most of the regulated markets of the world.